EP 1082097 A1 20010314 - USE OF SOPHOROLIPIDS COMPRISING DIACETYL LACTONES AS AGENT FOR STIMULATING SKIN FIBROBLAST METABOLISM
Title (en)
USE OF SOPHOROLIPIDS COMPRISING DIACETYL LACTONES AS AGENT FOR STIMULATING SKIN FIBROBLAST METABOLISM
Title (de)
VERWENDUNG VON DIACETYL- SOPHOROFETTSTOFFEN-LAKTONEN ALS STIMULIERUNGSMITTEL DES METABOLISMUS VON HAUTFIBROBLASTEN
Title (fr)
UTILISATION DE SOPHOROLIPIDES COMPRENANT DES LACTONES DIACETYLEES EN TANT QU'AGENT STIMULATEUR DU METABOLISME DES FIBROBLASTES DE LA PEAU
Publication
Application
Priority
- FR 9901245 W 19990527
- FR 9806789 A 19980529
Abstract (en)
[origin: FR2779057A1] The invention concerns the use of at least a sophorolipid in lactone form comprising a major part of diacetyl lactones as agent for stimulating skin dermal fibroblast cell metabolism and more particularly as agent for stimulating collagen neosynthesis, at a concentration of 0.01 ppm at 5 % (p/p) of dry matter in formulation. The invention is applicable in cosmetology and dermatology.
IPC 1-7
IPC 8 full level
A61K 8/00 (2006.01); A61K 8/35 (2006.01); A61K 8/365 (2006.01); A61K 8/37 (2006.01); A61K 8/49 (2006.01); A61K 8/60 (2006.01); A61K 8/67 (2006.01); A61K 31/715 (2006.01); A61Q 19/00 (2006.01)
CPC (source: EP US)
A61K 8/365 (2013.01 - EP US); A61K 8/37 (2013.01 - EP US); A61K 8/602 (2013.01 - EP US); A61Q 19/00 (2013.01 - EP US); A61Q 19/08 (2013.01 - EP US)
Citation (search report)
See references of WO 9962479A1
Designated contracting state (EPC)
DE ES GB IT NL
DOCDB simple family (publication)
FR 2779057 A1 19991203; FR 2779057 B1 20010615; CA 2333787 A1 19991209; EP 1082097 A1 20010314; JP 2002516836 A 20020611; US 6596265 B1 20030722; WO 9962479 A1 19991209
DOCDB simple family (application)
FR 9806789 A 19980529; CA 2333787 A 19990527; EP 99920934 A 19990527; FR 9901245 W 19990527; JP 2000551736 A 19990527; US 70141400 A 20001129